Subscribe To
Autolus Announces Pricing of Public Offering
LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of its previously announced underwritten public offering in the United States of 75,000,000 American Depositary Shares (“ADSs”) representing 75,000,000 ordinary shares at a public offering price of $2.00 per […] The post Autolus Announces Pricing of Public Offering appeared first on ForexTV...
Read More
Posted: Dec 9 2022, 02:11
Author Name: forextv
Views: 110724